Home / Inspections / 1181593

FDA Inspection 1181593 — Hospira Australia Pty Ltd.

Hospira Australia Pty Ltd. — FEI 3001174929

The FDA completed an inspection of Hospira Australia Pty Ltd. on September 2, 2022 in Mulgrave. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mulgrave (Australia)

Facility

Other inspections at this facility

  • 1100246 (NAI Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945591 (NAI Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 869582 (OAI Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 737223 (VAI Mon Mar 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 612891 (NAI Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources